Multiple studies have demonstrated that in addition to Aβ and tau, α-syn pathology can also be found in over 50 % of AD patients, suggesting that α-syn may also be involved in AD pathogenesis or that many AD patients have other neurodegenerative disease co-morbidities [162–165]. Here, MAPT is linked to Alzheimer disease.